NCT01941563View on ClinicalTrials.gov

A Study of SI-6603 in Patients With Lumbar Disc Herniation

PHASE3CompletedINTERVENTIONAL

Enrollment

385

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

August 31, 2017

Conditions

Intervertebral Disc DiseaseLumbar Disc Disease

Interventions

DRUG

Condoliase

1.25U, intradiscal injection, one time

DRUG

placebo

Trial Locations (32)

Unknown

Phoenix

Gold River

Laguna Hills

Los Gatos

Murrieta

Riverside

Denver

Hialeah

Jacksonville

Merritt Island

Miami

Naples

North Miami Beach

Orlando

Pinellas Park

Sarasota

St. Petersburg

Sunrise

Winter Park

Marietta

Newnan

Bloomington

Carmel

Shreveport

City of Saint Peters

Hartsdale

Eugene

State College

Charleston

Dallas

Sandy City

Edmonds

All Listed Sponsors

lead

Seikagaku Corporation

INDUSTRY

NCT01941563 - A Study of SI-6603 in Patients With Lumbar Disc Herniation | Biotech Hunter | Biotech Hunter